Case Reports in Medicine
Volume 2018 (2018), Article ID 2313927, 3 pages
https://doi.org/10.1155/2018/2313927

Case Report

A Rare Case of Monophasic Synovial Sarcoma of Thoracic Vertebra

Sana Najib, Tahmina Saleem, Ali Nadhim, and Shuvendu Sen

Raritan Bay Medical Center, Perth Amboy, NJ, USA

Correspondence should be addressed to Sana Najib; sananajib@yahoo.com

Received 6 July 2018; Accepted 30 September 2018; Published 18 November 2018

Academic Editor: Isidro Machado

Copyright © 2018 Sana Najib et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Synovial sarcoma of spine is an extremely rare malignancy with poor prognosis. It is often metastatic at the time of presentation. Its relative rarity and histological resemblance to other tumors make it diagnostically challenging, requiring the need of immunohistochemistry and cytogenetics for definite diagnosis. Surgery is the mainstay of therapy with adjunct chemotherapy, although survival rates are very low.

1. Introduction

Synovial sarcoma is a rare, soft tissue tumor comprising only 5% of all soft tissue sarcomas [1, 2]. It predominantly arises in the deep tissues of extremities, with only 5% arising from the axial skeleton [3]. It usually affects young adults and has a male predominance [4]. It has a very poor prognosis with metastatic disease, with survival rates of less than 2% over 5 years.

2. Case Presentation

A 44-year-old male with no significant past medical history presented to us with the complaint of lower back pain radiating to both groins for the last 2 months. Vitals at presentation were BP of 120/70 mm Hg, pulse of 82, RR of 18/minute, and T of 98.9°F. Physical exam and lab work were unremarkable. CT scan showed a sclerotic and lytic lesion in T12 (Figure 1). Further investigation with CT scan of chest revealed multiple bilateral pulmonary nodules along with mediastinal and hilar lymphadenopathy suggestive of a metastatic malignant process (Figure 2). CT-guided biopsy of a pulmonary nodule showed malignant neoplasm with spindle cells (Figure 3). Immunohistochemical stains showed tumor cells positive for Bcl-2, vimentin, EMA, CD56, CD99, and TLE-1 and negative for CD34, CD10, P63, cytokeratin, S100, desmin, and synaptophysin. Interphase FISH was performed and was positive for a rearrangement involving SYT gene (18q11) consistent with a synovial sarcoma. Biopsy of the T2 lesion showed exactly the same IHC and FISH findings. The whole-body CT scan for extrathoracic disease was negative. The patient was referred to another facility for further management.

Figure 1: Sclerotic and lytic lesions at t12.

Figure 2: Bilateral pulmonary nodules.

Figure 3: Histology with H&E staining and high-power magnification showing spindle cells suggestive of monophasic variant of synovial sarcoma.

3. Discussion

Synovial sarcoma of the spine is an extremely rare tumor. It has multiple subtypes, out of which monophasic (spindle cell carcinoma) has close histological resemblance to other tumors including fibrosarcoma, leiomyosarcoma, and spindle cell variant of squamous cell carcinoma that are relatively more common. Histopathology is insufficient to make diagnosis, and immunohistochemistry is mandatory to rule out other neoplasms on differentials [5]. In the past, IHC has been used as the sole method of diagnosis but review of the literature has shown cases, where IHC was inconclusive showing synovial sarcoma to be positive for markers such as S-100 making diagnosis challenging (Figure 4). Advances in cytogenetics have revealed that the definitive diagnosis of synovial sarcoma can be made only by evidence of a translocation t(X : 18) characterized by fusion of the SYT gene (Figure 5) on chromosome 18 with SSX genes on X chromosome resulting in a chimeric protein [5]. Recently, this gene product is the target for the development of newer antineoplastic agents for synovial sarcoma that are under clinical trials (Figure 5).

Figure 4: TLE-1 immunohistochemistry.

Figure 5: FISH showing SYT split.

4. Conclusion

This case report raises the awareness about synovial sarcoma, a rare malignancy with extremely poor prognosis. Refractory back pain in a young patient should be investigated properly for any possibility of a malignant process. This malignancy is diagnostically challenging, requiring cytogenetic translocation for definitive diagnosis [5]. Although prognosis is poor, favorable outcomes have been seen in cases with early detection and appropriate surgical management with adjunctive chemotherapy and radiotherapy [6].

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

S. M. Koehler, M. B. Beasley, C. S. Chin, J. C. Wittig, A. C. Hecht, and S. A. Qureshi, “Synovial sarcoma of the thoracic spine,” Spine Journal, vol. 9, no. 12, pp. e1–e6, 2009.

W. Shi, D. J. Indelicato, C. G. Morris, M. T. Scarborough, C. P. Gibbs, and R. A. Zlotecki, “Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida,” American Journal of Clinical Oncology, vol. 36, no. 1, pp. 83–88, 2013.

K. Thway and C. Fisher, “Synovial sarcoma: defining features and diagnostic evolution,” Annals of Diagnostic Pathology, vol. 18, no. 6, pp. 369–380, 2014.

M. J. Clarke, R. C. Puffer, D. J. Daniels, C. Giannini, M. A. Pichelmann, and P. S. Rose, “Synovial sarcoma of the spine: a report of three cases and review of the literature,” Surgical Neurology International, vol. 2, no. 1, p. 18, 2011.

M. Patentalakis, M. Mermigkis, A. Kopanakis et al., “Primary monophasic synovial sarcoma presenting as a pulmonary mass: a case report,” Journal of Medical Case Reports, vol. 2, no. 1, p. 18, 2008.

S. M. Foreman and M. J. Stahl, “Biphasic synovial sarcoma in the cervical spine: Case report,” Chiropractic & Manual Therapies, vol. 19, no. 1, p. 12, 2011.